16 results on '"Fan, Xia"'
Search Results
2. High-quality-draft genome sequence of the heavy metal resistant and exopolysaccharides producing bacterium Mucilaginibacter pedocola TBZ30T
- Author
-
Fan, Xia, Tang, Jingwei, Nie, Li, Huang, Jing, and Wang, Gejiao
- Published
- 2018
- Full Text
- View/download PDF
3. Effects of medical resource capacities and intensities of public mitigation measures on outcomes of COVID-19 outbreaks
- Author
-
Xia Wang, Pengfei Song, Jianhong Wu, Qian Li, Sanyi Tang, Robert Cheke, Xiaodan Sun, Yanni Xiao, Fan Xia, Yiming Shao, and Sha He
- Subjects
Mainland China ,medicine.medical_specialty ,China ,S1 ,Resource (biology) ,Time Factors ,Epidemiology ,030231 tropical medicine ,Control (management) ,Logistic regression ,Disease Outbreaks ,1117 Public Health and Health Services ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,Pandemic ,medicine ,Humans ,030212 general & internal medicine ,Pandemics ,Public, Environmental & Occupational Health ,Science & Technology ,business.industry ,SARS-CoV-2 ,lcsh:Public aspects of medicine ,Public health ,Mortality rate ,Public Health, Environmental and Occupational Health ,COVID-19 ,lcsh:RA1-1270 ,Runs on medical resources ,Models, Theoretical ,Health Resources ,Business ,Public Health ,Biostatistics ,Epidemic model ,Prediction ,Life Sciences & Biomedicine ,Delivery of Health Care ,Research Article ,Model ,Inter-country comparisons - Abstract
BackgroundThe COVID-19 pandemic is complex and is developing in different ways according to the country involved.MethodsTo identify the key parameters or processes that have the greatest effects on the pandemic and reveal the different progressions of epidemics in different countries, we quantified enhanced control measures and the dynamics of the production and provision of medical resources. We then nested these within a COVID-19 epidemic transmission model, which is parameterized by multi-source data. We obtained rate functions related to the intensity of mitigation measures, the effective reproduction numbers and the timings and durations of runs on medical resources, given differing control measures implemented in various countries.ResultsIncreased detection rates may induce runs on medical resources and prolong their durations, depending on resource availability. Nevertheless, improving the detection rate can effectively and rapidly reduce the mortality rate, even after runs on medical resources. Combinations of multiple prevention and control strategies and timely improvement of abilities to supplement medical resources are key to effective control of the COVID-19 epidemic. A 50% reduction in comprehensive control measures would have led to the cumulative numbers of confirmed cases and deaths exceeding 590,000 and 60,000, respectively, by 27 March 2020 in mainland China.ConclusionsMultiple data sources and cross validation of a COVID-19 epidemic model, coupled with a medical resource logistic model, revealed the key factors that affect epidemic progressions and their outbreak patterns in different countries. These key factors are the type of emergency medical response to avoid runs on medical resources, especially improved detection rates, the ability to promote public health measures, and the synergistic effects of combinations of multiple prevention and control strategies. The proposed model can assist health authorities to predict when they will be most in need of hospital beds and equipment such as ventilators, personal protection equipment, drugs, and staff.
- Published
- 2021
4. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study
- Author
-
Meiying Wu, Wenpei Shi, Zhu Ning, Xubin Zheng, Yue O. O. Hu, Yi Hu, Biao Xu, Stefanie Prast-Nielsen, and Fan Xia
- Subjects
Male ,Antitubercular Agents ,Gut flora ,Adverse effect ,Study Protocol ,0302 clinical medicine ,Prospective Studies ,Treatment outcome ,Prospective cohort study ,16S rRNA gene sequencing ,0303 health sciences ,biology ,Incidence ,Pulmonary tuberculosis ,Middle Aged ,030220 oncology & carcinogenesis ,Female ,Chinese cohort ,medicine.drug ,Pulmonary and Respiratory Medicine ,Adult ,DNA, Bacterial ,medicine.medical_specialty ,China ,Tuberculosis ,Adolescent ,Gut microbiota ,digestive system ,03 medical and health sciences ,Young Adult ,Internal medicine ,medicine ,Humans ,Ethambutol ,030304 developmental biology ,Aged ,lcsh:RC705-779 ,business.industry ,lcsh:Diseases of the respiratory system ,Mycobacterium tuberculosis ,Pyrazinamide ,biology.organism_classification ,medicine.disease ,Gastrointestinal Microbiome ,Clinical trial ,Gastrointestinal function ,business ,Follow-Up Studies - Abstract
Background Anti-tuberculosis therapy requires at least six-month treatment with continuous administration of combined antibiotics, including isoniazid, rifampicin, pyrazinamide, and ethambutol. The long-term exposure to antibiotics could cause consequent changes in gut microbiota, which may alter the gastrointestinal function and drug absorption in patients, thereby affect the outcome of treatment. The study aims to characterize the longitudinal changes of gut microbiota among tuberculosis (TB) patients under standardized first-line treatment and provide an understanding of the association between alterations in gut microbiota composition and unfavorable clinical outcomes. Methods The study is a multicenter, observational prospective cohort study. Three study sites are purposively selected in the western (Sichuan Province) and eastern (Jiangsu Province and Shanghai) parts of China. Three-hundred patients with bacteriologically confirmed pulmonary TB are enrolled. All eligible patients should be investigated using structured questionnaires before treatment initiation; and be followed up during the treatment at Day-14, Month-2, Month-5, the end of treatment and the sixth month after ending therapy. Stool samples are to be collected at each visit, consisting of six stool samples from each patient. Additionally, 60 healthy volunteers from Sichuan province and Shanghai city will be recruited as healthy controls to form the baseline of patient gut microbiota in the Chinese population. The dynamic changes of gut microbiota in terms of alpha diversity, beta diversity, taxonomic composition are to be illustrated individually from the time at diagnosis until the sixth month after therapy is completed. Furthermore, the diversity and component of gut microbiota will be compared between the groups with and without unfavorable treatment outcome in terms of adverse effect and treatment failure. Discussion Studies on the clinical manifestations, adverse reactions, and gut microbiota alterations will provide scientifically-sound evidence on the impact of gut microbiota alterations on TB treatment outcomes. The study is not only useful for guiding personalized TB treatment but also sheds light on the effects of continuous antibiotics administration on gut microbiota. Trial registration Chinese Clinical Trial Registry, trial ID: ChiCTR1900023369, May 24, 2019. Retrospectively registered.
- Published
- 2019
5. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism
- Author
-
Marianne McGuire, Daryl A. Scott, Jason Brown, Sonal Mahida, Hyung-Goo Kim, Jonathan D J Labonne, Eric Muller, Arthur Sorlin, Vincent des Portes, Duchwan Ryu, Gerard Bénédicte, Fan Xia, Zeyaul Islam, Suneeta Madan-Khetarpal, Sakkubai Naidu, Jill A. Rosenfeld, Il-Keun Kong, Dianalee McKnight, Erin Torti, Lawrence C. Layman, Jacqueline Gutierrez, Franz Rüschendorf, Gaetan Lesca, Yline Capri, Oliver Hummel, Cheol-Hee Kim, Ange Line Bruel, and Prasanna R. Kolatkar
- Subjects
Male ,lcsh:RC346-429 ,Craniofacial Abnormalities ,Intellectual disability (ID) ,Missense mutation ,Potocki-Shaffer syndrome (PSS) ,Child ,Exome sequencing ,Genetics ,0303 health sciences ,030305 genetics & heredity ,Neurodevelopmental disorders ,Brain ,Syndrome ,Autism spectrum disorder (ASD) ,Hypotonia ,Psychiatry and Mental health ,Autism spectrum disorder ,Child, Preschool ,Muscle Hypotonia ,Female ,medicine.symptom ,Haploinsufficiency ,BHC80 ,Adolescent ,Nonsense mutation ,Histone Deacetylases ,Frameshift mutation ,Intrinsically disordered region (IDR) ,03 medical and health sciences ,Developmental Neuroscience ,Protein Domains ,Intellectual Disability ,medicine ,Humans ,AT Hook domain ,Amino Acid Sequence ,RNA, Messenger ,Autistic Disorder ,Molecular Biology ,lcsh:Neurology. Diseases of the nervous system ,030304 developmental biology ,Behavior ,Epilepsy ,business.industry ,Research ,Infant, Newborn ,Infant ,medicine.disease ,PHF21A ,Cardiovascular and Metabolic Diseases ,KDM1A ,Mutation ,Autism ,business ,Developmental Biology - Abstract
Background PHF21A has been associated with intellectual disability and craniofacial anomalies based on its deletion in the Potocki-Shaffer syndrome region at 11p11.2 and its disruption in three patients with balanced translocations. In addition, three patients with de novo truncating mutations in PHF21A were reported recently. Here, we analyze genomic data from seven unrelated individuals with mutations in PHF21A and provide detailed clinical descriptions, further expanding the phenotype associated with PHF21A haploinsufficiency. Methods Diagnostic trio whole exome sequencing, Sanger sequencing, use of GeneMatcher, targeted gene panel sequencing, and MiSeq sequencing techniques were used to identify and confirm variants. RT-qPCR was used to measure the normal expression pattern of PHF21A in multiple human tissues including 13 different brain tissues. Protein-DNA modeling was performed to substantiate the pathogenicity of the missense mutation. Results We have identified seven heterozygous coding mutations, among which six are de novo (not maternal in one). Mutations include four frameshifts, one nonsense mutation in two patients, and one heterozygous missense mutation in the AT Hook domain, predicted to be deleterious and likely to cause loss of PHF21A function. We also found a new C-terminal domain composed of an intrinsically disordered region. This domain is truncated in six patients and thus likely to play an important role in the function of PHF21A, suggesting that haploinsufficiency is the likely underlying mechanism in the phenotype of seven patients. Our results extend the phenotypic spectrum of PHF21A mutations by adding autism spectrum disorder, epilepsy, hypotonia, and neurobehavioral problems. Furthermore, PHF21A is highly expressed in the human fetal brain, which is consistent with the neurodevelopmental phenotype. Conclusion Deleterious nonsense, frameshift, and missense mutations disrupting the AT Hook domain and/or an intrinsically disordered region in PHF21A were found to be associated with autism spectrum disorder, epilepsy, hypotonia, neurobehavioral problems, tapering fingers, clinodactyly, and syndactyly, in addition to intellectual disability and craniofacial anomalies. This suggests that PHF21A is involved in autism spectrum disorder and intellectual disability, and its haploinsufficiency causes a diverse neurological phenotype.
- Published
- 2019
6. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder
- Author
-
Salma Nassef, Linyan Meng, Rui Xiao, Xia Wang, Magdalena Walkiewicz, Christine M. Eng, Hongzheng Dai, Pengfei Liu, Elizabeth A. Normand, Weimin Bi, Chunjing Qu, Francesco Vetrini, Richard A. Gibbs, Patricia A. Ward, Weimin He, Avinash V. Dharmadhikari, Vipulkumar Patel, Ignatia B. Van den Veyver, Donna M. Muzny, Alicia Braxton, Samantha Stover, Fan Xia, Lauren E. Westerfield, and Yaping Yang
- Subjects
0301 basic medicine ,Exome sequencing ,Pediatrics ,medicine.medical_specialty ,lcsh:QH426-470 ,Inheritance Patterns ,lcsh:Medicine ,Autopsy ,Prenatal diagnosis ,030105 genetics & heredity ,Ultrasonography, Prenatal ,03 medical and health sciences ,Fetus ,Genetics ,Medicine ,Prenatal ,Humans ,Family ,Medical diagnosis ,Molecular Biology ,Exome ,Genetics (clinical) ,business.industry ,Research ,lcsh:R ,Genetic Diseases, Inborn ,Human genetics ,Single-gene disorder ,Exact test ,lcsh:Genetics ,Phenotype ,Molecular Medicine ,Mendelian disease ,business ,Fetal structural abnormalities - Abstract
Background Exome sequencing is now being incorporated into clinical care for pediatric and adult populations, but its integration into prenatal diagnosis has been more limited. One reason for this is the paucity of information about the clinical utility of exome sequencing in the prenatal setting. Methods We retrospectively reviewed indications, results, time to results (turnaround time, TAT), and impact of exome results for 146 consecutive “fetal exomes” performed in a clinical diagnostic laboratory between March 2012 and November 2017. We define a fetal exome as one performed on a sample obtained from a fetus or a product of conception with at least one structural anomaly detected by prenatal imaging or autopsy. Statistical comparisons were performed using Fisher’s exact test. Results Prenatal exome yielded an overall molecular diagnostic rate of 32% (n = 46/146). Of the 46 molecular diagnoses, 50% were autosomal dominant disorders (n = 23/46), 41% were autosomal recessive disorders (n = 19/46), and 9% were X-linked disorders (n = 4/46). The molecular diagnostic rate was highest for fetuses with anomalies affecting multiple organ systems and for fetuses with craniofacial anomalies. Out of 146 cases, a prenatal trio exome option designed for ongoing pregnancies was performed on 62 fetal specimens, resulting in a diagnostic yield of 35% with an average TAT of 14 days for initial reporting (excluding tissue culture time). The molecular diagnoses led to refined recurrence risk estimates, altered medical management, and informed reproductive planning for families. Conclusion Exome sequencing is a useful diagnostic tool when fetal structural anomalies suggest a genetic etiology, but other standard prenatal genetic tests did not provide a diagnosis. Electronic supplementary material The online version of this article (10.1186/s13073-018-0582-x) contains supplementary material, which is available to authorized users.
- Published
- 2018
7. POGZ truncating alleles cause syndromic intellectual disability
- Author
-
James R. Lupski, Richard A. Gibbs, Zöe Powis, Jing Zhang, Donna M. Muzny, Jennifer E. Posey, Daniel K. Arrington, Jill A. Rosenfeld, Eric Boerwinkle, Janice Baker, Fan Xia, Melissa Hall, V. Reid Sutton, Zhiyv Niu, Nancy J. Mendelsohn, Richard E. Person, Apostolos Psychogios, Kati J. Mason, Lynda Pollack, Magdalena Walkiewicz, Sha Tang, Janson White, Christine M. Eng, Shalini N. Jhangiani, Christine R. Beck, Kelly D. Farwell, Tamar Harel, Arthur L. Beaudet, Yaping Yang, Laura Fairbrother, and Klaas J. Wierenga
- Subjects
0301 basic medicine ,Adult ,Male ,Microcephaly ,Heterozygote ,Adolescent ,Transposases ,Biology ,Bioinformatics ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Intellectual Disability ,Intellectual disability ,Genetics ,medicine ,Humans ,Genetics(clinical) ,Exome ,Molecular Biology ,Genetics (clinical) ,Exome sequencing ,Alleles ,Sanger sequencing ,Research ,Infant ,Sequence Analysis, DNA ,medicine.disease ,Hypotonia ,Human genetics ,030104 developmental biology ,Autism spectrum disorder ,Child, Preschool ,Mutation ,symbols ,Molecular Medicine ,Female ,medicine.symptom ,030217 neurology & neurosurgery - Abstract
Background Large-scale cohort-based whole exome sequencing of individuals with neurodevelopmental disorders (NDDs) has identified numerous novel candidate disease genes; however, detailed phenotypic information is often lacking in such studies. De novo mutations in pogo transposable element with zinc finger domain (POGZ) have been identified in six independent and diverse cohorts of individuals with NDDs ranging from autism spectrum disorder to developmental delay. Methods Whole exome sequencing was performed on five unrelated individuals. Sanger sequencing was used to validate variants and segregate mutations with the phenotype in available family members. Results We identified heterozygous truncating mutations in POGZ in five unrelated individuals, which were confirmed to be de novo or not present in available parental samples. Careful review of the phenotypes revealed shared features that included developmental delay, intellectual disability, hypotonia, behavioral abnormalities, and similar facial characteristics. Variable features included short stature, microcephaly, strabismus and hearing loss. Conclusions While POGZ has been associated with neurodevelopmental disorders in large cohort studies, our data suggest that loss of function variants in POGZ lead to an identifiable syndrome of NDD with specific phenotypic traits. This study exemplifies the era of human reverse clinical genomics ushered in by large disease-directed cohort studies; first defining a new syndrome molecularly and, only subsequently, phenotypically.
- Published
- 2016
8. De novo deletions and duplications of 17q25.3 cause susceptibility to cardiovascular malformations
- Author
-
Stephanie M. Ware, Seema R. Lalani, Weimin Bi, Regis A. James, Carlos A. Bacino, Fan Xia, Elise G. Austin, John W. Belmont, Jill A. Rosenfeld, C. H. Ward Melver, Lindsay C. Burrage, S.W. Cheung, Chad A. Shaw, Frank J. Probst, Mahshid S. Azamian, Ankita Patel, Pilar L. Magoulas, T. P. Bohan, and A. I. A. Franklin
- Subjects
Heart Defects, Congenital ,Male ,medicine.medical_specialty ,DNA Copy Number Variations ,Intellectual disability ,Locus (genetics) ,Biology ,Bioinformatics ,Gene duplication ,medicine ,Humans ,Genetics(clinical) ,Pharmacology (medical) ,Genetic Predisposition to Disease ,Copy-number variation ,Copy number variations ,Genetics (clinical) ,Medicine(all) ,Genetics ,Research ,Cytogenetics ,Infant, Newborn ,Infant ,General Medicine ,Human genetics ,3. Good health ,17q25 Deletion ,Congenital heart defects ,Child, Preschool ,Medical genetics ,Female ,Chromosome Deletion ,Haploinsufficiency ,Comparative genomic hybridization ,Chromosomes, Human, Pair 17 - Abstract
Background Genomic disorders resulting from deletion or duplication of genomic segments are known to be an important cause of cardiovascular malformations (CVMs). In our previous study, we identified a unique individual with a de novo 17q25.3 deletion from a study of 714 individuals with CVM. Methods To understand the contribution of this locus to cardiac malformations, we reviewed the data on 60,000 samples submitted for array comparative genomic hybridization (CGH) studies to Medical Genetics Laboratories at Baylor College of Medicine, and ascertained seven individuals with segmental aneusomy of 17q25. We validated our findings by studying another individual with a de novo submicroscopic deletion of this region from Cytogenetics Laboratory at Cincinnati Children’s Hospital. Using bioinformatic analyses including protein-protein interaction network, human tissue expression patterns, haploinsufficiency scores, and other annotation systems, including a training set of 251 genes known to be linked to human cardiac disease, we constructed a pathogenicity score for cardiac phenotype for each of the 57 genes within the terminal 2.0 Mb of 17q25.3. Results We found relatively high penetrance of cardiovascular defects (~60 %) with five deletions and three duplications, observed in eight unrelated individuals. Distinct cardiac phenotypes were present in four of these subjects with non-recurrent de novo deletions (range 0.08 Mb–1.4 Mb) in the subtelomeric region of 17q25.3. These included coarctation of the aorta (CoA), total anomalous pulmonary venous return (TAPVR), ventricular septal defect (VSD) and atrial septal defect (ASD). Amongst the three individuals with variable size duplications of this region, one had patent ductus arteriosus (PDA) at 8 months of age. Conclusion The distinct cardiac lesions observed in the affected patients and the bioinformatics analyses suggest that multiple genes may be plausible drivers of the cardiac phenotype within this gene-rich critical interval of 17q25.3. Electronic supplementary material The online version of this article (doi:10.1186/s13023-015-0291-0) contains supplementary material, which is available to authorized users.
- Published
- 2015
9. Depressive symptoms and negative life events: What psycho-social factors protect or harm left-behind children in China?
- Author
-
Yu Guang, Zhengzhi Feng, Guoyu Yang, Yaling Yang, Lifei Wang, Qin Dai, Chaobing Hu, Keyu Liu, Rui Zhang, Fan Xia, and Mengxue Zhao
- Subjects
MENTAL depression ,PSYCHOSOCIAL factors ,CHILD psychology ,FAMILY relations ,ANALYSIS of variance ,ACADEMIC achievement - Abstract
Background: In China, children under 18 years old who are left at rural residences for at least 6 months by either one or both of their parents migrating to work in cities are called "left-behind children (LBC)". Due to restricted family support, they are at a greater risk of developing depressive symptoms than non-left-behind children (NLBC). The objective of this study is to explore how depressive symptoms and stress induced by negative life events such as interpersonal conflicts, punishment and loss, as well as their relationships vary for LBC with different left-behind-related characteristics. Methods: Using data from a large school-based survey conducted in Chongqing between December 2012 and June 2013, we first identified the differences in depressive symptoms and negative-event-induced stress between LBC and NLBC, and then analyzed the variances among LBC with different left-behind-related characteristics. The data was analyzed with Chi-square test, MANCOVA, ANCOVA, ANOVA, T-test and hierarchical multiple regression analyses. Results: We found that LBC were more stressed when experiencing negative events and had more depressive symptoms than NLBC. Children left behind by both parents were most depressed. Negative-event-induced stress and communication on life difficulties with migrant parents were risk factors for depressive symptoms, whereas adequate communication on academic performance or children's feelings was a protective factor against depressive symptoms. Communication duration and frequency, communication by visiting, communication on academic performance, life difficulties and children's feelings moderated the relationship between stress and depressive symptoms, respectively. Duration of separation, communication duration and frequency, communication on academic performance, learning difficulties and children's feelings moderated the relation between the type of parental migration and depressive symptoms, respectively. Conclusions: Our findings suggest that children left behind by both parents should be the focus of public attention for their higher susceptibility to stress-related depression. To help LBC stay mentally healthy, governments need to formulate regulations contributing to LBC's family reunion, communities need to involve more residents to attend LBC as "surrogate parents" and teach migrant parents to communicate with LBC properly, and schools need to teach LBC how to deal with stress and communicate with migrant parents. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
10. Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders.
- Author
-
Bostwick, Bret L., McLean, Scott, Posey, Jennifer E., Streff, Haley E., Gripp, Karen W., Blesson, Alyssa, Powell-Hamilton, Nina, Tusi, Jessica, Stevenson, David A., Farrelly, Ellyn, Hudgins, Louanne, Yaping Yang, Fan Xia, Xia Wang, Pengfei Liu, Walkiewicz, Magdalena, McGuire, Marianne, Grange, Dorothy K., Andrews, Marisa V., and Hummel, Marybeth
- Subjects
CONGENITAL heart disease ,CYCLIN-dependent kinases ,FACIAL abnormalities ,DEVELOPMENTAL delay ,EXOMES ,NUCLEOTIDE sequence - Abstract
Background: De novo missense variants in CDK13 have been described as the cause of syndromic congenital heart defects in seven individuals ascertained from a large congenital cardiovascular malformations cohort. We aimed to further define the phenotypic and molecular spectrum of this newly described disorder. Methods: To minimise ascertainment bias, we recruited nine additional individuals with CDK13 pathogenic variants from clinical and research exome laboratory sequencing cohorts. Each individual underwent dysmorphology exam and comprehensive medical history review. Results: We demonstrate greater than expected phenotypic heterogeneity, including 33% (3/9) of individuals without structural heart disease on echocardiogram. There was a high penetrance for a unique constellation of facial dysmorphism and global developmental delay, as well as less frequently seen renal and sacral anomalies. Two individuals had novel CDK13 variants (p.Asn842Asp, p.Lys734Glu), while the remaining seven unrelated individuals had a recurrent, previously published p.Asn842Ser variant. Summary of all variants published to date demonstrates apparent restriction of pathogenic variants to the protein kinase domain with clustering in the ATP and magnesium binding sites. Conclusions: Here we provide detailed phenotypic and molecular characterisation of individuals with pathogenic variants in CDK13 and propose management guidelines based upon the estimated prevalence of anomalies identified. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate.
- Author
-
Wu-Lin Charng, Karaca, Ender, Coban Akdemir, Zeynep, Gambin, Tomasz, Atik, Mehmed M., Shen Gu, Posey, Jennifer E., Jhangiani, Shalini N., Muzny, Donna M., Doddapaneni, Harsha, Jianhong Hu, Boerwinkle, Eric, Gibbs, Richard A., Rosenfeld, Jill A., Hong Cui, Fan Xia, Manickam, Kandamurugu, Yaping Yang, Faqeih, Eissa A., and Al Asmari, Ali
- Subjects
EXOMES ,NUCLEOTIDE sequencing ,DNA analysis ,NUCLEOTIDE analysis ,NEURODEVELOPMENTAL treatment - Abstract
Background: Neurodevelopment is orchestrated by a wide range of genes, and the genetic causes of neurodevelopmental disorders are thus heterogeneous. We applied whole exome sequencing (WES) for molecular diagnosis and in silico analysis to identify novel disease gene candidates in a cohort from Saudi Arabia with primarily Mendelian neurologic diseases. Methods: We performed WES in 31 mostly consanguineous Arab families and analyzed both single nucleotide and copy number variants (CNVs) from WES data. Interaction/expression network and pathway analyses, as well as paralog studies were utilized to investigate potential pathogenicity and disease association of novel candidate genes. Additional cases for candidate genes were identified through the clinical WES database at Baylor Miraca Genetics Laboratories and GeneMatcher. Results: We found known pathogenic or novel variants in known disease genes with phenotypic expansion in 6 families, disease-associated CNVs in 2 families, and 12 novel disease gene candidates in 11 families, including KIF5B, GRM7, FOXP4, MLLT1, and KDM2B. Overall, a potential molecular diagnosis was provided by variants in known disease genes in 17 families (54.8 %) and by novel candidate disease genes in an additional 11 families, making the potential molecular diagnostic rate ~90 %. Conclusions: Molecular diagnostic rate from WES is improved by exome-predicted CNVs. Novel candidate disease gene discovery is facilitated by paralog studies and through the use of informatics tools and available databases to identify additional evidence for pathogenicity. Trial registration: Not applicable. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. BurnCalc-Assessment study of computer-aided individual 3-dimensional burn area calculation.
- Author
-
Wen-bo Sheng, Ding Zeng, Yan Wan, Li Yao, Hong-tai Tang, and Zhao-fan Xia
- Subjects
BURNS & scalds ,COMPUTER-aided dispatch systems ,BODY surface area ,PREDICTION models ,CLINICAL trials ,PROGNOSIS - Abstract
Background Accurate estimation of a burned area is crucial to decisions about fluid resuscitation, surgical options, nutritional support, and prognosis. Widely used clinical methods to estimate a burn area are two-dimensional. They do not consider age, sex, body mass, physical deformities, or other relevant factors. Computer-aided methods have improved the accuracy of estimating burned areas by including data analysis and reducing subjective differences. Threedimensional (3D) scanning allows us to determine body dimensions rapidly and reproducibly. We describe an individualized, cost-efficient, portable 3D scanning system, BurnCalc, that can create an individual 3D model and then calculate body surface area (BSA) and the burn area accurately and quickly. Methods The BurnCalc system was validated by verifying the accuracy and stability of BSA calculation. We measured 10 regular objects in experiment 1, using Student's t-test and the intraclass correlation coefficient (ICC) in the analysis. In experiment 2, artificial paper patches of known dimensions were attached to various parts of the body of 40 volunteers. Their sizes were then calculated using BurnCalc. The BurnCalc data were compared to actually measured values to verify accuracy and stability. Total BSAs of these 40 volunteers were also calculated by BurnCalc and compared to those derived from an accepted formula. In experiment 3, four experts using Chinese Rule-of-Nines or Rule-of-Palms methods calculated the percentages of the total BSA in 17 volunteers. Student's t-test and ICC, respectively, were used to compare the results obtained with the BurnCalc technique. Results Statistically, in experiment 1, p = 0.834 and ICC = 0.999, demonstrating that there was no difference between the BurnCalc and real measurements. Also, the hypothesis of null difference among measures (experiment 2) was true because p > 0.05 and ICC = 0.999, indicating that calculations of the total BSA and the burn area were more accurate using the BurnCalc technology. The reliability of the BurnCalc program was 99.9%. In experiment 3, only the BurnCalc method exhibited values of p > 0.05 (p = 0.774) and ICC = 0.999. Conclusions BurnCalc technology produced stable, accurate readings, suggesting that BurnCalc could be regarded as a new standard clinical method. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines.
- Author
-
Chunfang Zhang, Jinyong Peng, Shan Wu, Yue Jin, Fan Xia, Changyuan Wang, Kexin Liu, Huijun Sun, and Mozhen Liu2
- Subjects
SAPONINS ,CELL lines ,BONE diseases ,VITAMIN D deficiency ,STEROID hormones - Abstract
Background Dioscin, a typical steroid saponin, is isolated from Dioscorea nipponica Makino and Dioscorea zingiberensis Wright. It has estrogenic activity and many studies have also reported that dioscorea plants have an effect in preventing and treating osteoporosis. However, the molecular mechanisms underlying their effect on osteoporosis treatment are poorly understood. Therefore, the present study aims to investigate the mechanism (s) by which dioscin promotes osteoblastic proliferation and differentiation in mouse pre-osteoblast like MC3T3-E1 cells and human osteoblast-like MG-63 cells. Results We found that dioscin (0.25 μg/ml, 0.5 μg/ml, and 1.0 μg/ml) promoted MC3T3-E1 cells and MG-63 cells proliferation and differentiation dose dependently. Western blot analysis results showed that estrogen receptor α (ER-α), estrogen receptor β (ER-β), β-catenin and Bcl-2 protein expression increased after MC3T3-E1 cells were treated with dioscin. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that dioscin could increase the ratio of osteoprotegerin (OPG)/ receptor activator of NF-κB ligand (RANKL) and up-regulate the level of Lrp5 and β-catenin. And by RNA interference analysis, we proved that the effect of dioscin increasing the ratio of OPG/ RANKL was dependent on Lrp5 pathway. In addition, we also found that these effects of dioscin were abolished by ICI 182, 780 (100 nM), an antagonist of ER, indicating that an ER signaling pathway was also involved. We also found that dioscin (0.25 μg/ml, 0.5 μg/ml, and 1.0 μg/ml) induced MG-63 cells proliferation and differentiation in a dose-dependent manner. Western blot analysis results indicated that ER-α, ER-β and β-catenin protein expression increased after MG-63 cells were treated with dioscin. Conclusions The current study is the first to reveal that dioscin can promote osteoblasts proliferation and differentiation via Lrp5 and ER pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. High-quality-draft genome sequence of the heavy metal resistant and exopolysaccharides producing bacterium Mucilaginibacter pedocola TBZ30T.
- Author
-
Fan, Xia, Tang, Jingwei, Nie, Li, Huang, Jing, and Wang, Gejiao
- Subjects
- *
GENOMES , *NUCLEOTIDE sequencing , *GRAM-negative bacteria , *PHYLOGENY , *GENES - Abstract
Mucilaginibacter pedocola TBZ30T (= CCTCC AB 2015301T = KCTC 42833T) is a Gram- negative, rod-shaped, non-motile and non-spore-forming bacterium isolated from a heavy metal contaminated paddy field. It shows resistance to multiple heavy metals and can adsorb/remove Zn2+ and Cd2+ during cultivation. In addition, strain TBZ30T produces exopolysaccharides (EPS). These features make it a great potential to bioremediate heavy metal contamination and biotechnical application. Here we describe the genome sequence and annotation of strain TBZ30T. The genome size is 7,035,113 bp, contains 3132 protein-coding genes (2736 with predicted functions), 50 tRNA encoding genes and 14 rRNA encoding genes. Putative heavy metal resistant genes and EPS associated genes are found in the genome. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. High-quality-draft genome sequence of the heavy metal resistant and exopolysaccharides producing bacterium Mucilaginibacter pedocola TBZ30T.
- Author
-
Fan, Xia, Tang, Jingwei, Nie, Li, Huang, Jing, and Wang, Gejiao
- Subjects
GENOMES ,NUCLEOTIDE sequencing ,GRAM-negative bacteria ,PHYLOGENY ,GENES - Abstract
Mucilaginibacter pedocola TBZ30
T (= CCTCC AB 2015301T = KCTC 42833T ) is a Gram- negative, rod-shaped, non-motile and non-spore-forming bacterium isolated from a heavy metal contaminated paddy field. It shows resistance to multiple heavy metals and can adsorb/remove Zn2+ and Cd2+ during cultivation. In addition, strain TBZ30T produces exopolysaccharides (EPS). These features make it a great potential to bioremediate heavy metal contamination and biotechnical application. Here we describe the genome sequence and annotation of strain TBZ30T . The genome size is 7,035,113 bp, contains 3132 protein-coding genes (2736 with predicted functions), 50 tRNA encoding genes and 14 rRNA encoding genes. Putative heavy metal resistant genes and EPS associated genes are found in the genome. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
16. Modulating autophagy: a strategy for cancer therapy.
- Author
-
Li JL, Han SL, and Fan X
- Subjects
- Antineoplastic Agents pharmacology, Apoptosis drug effects, Cell Transformation, Neoplastic drug effects, Drug Resistance, Neoplasm, Humans, NF-kappa B pharmacology, Neoplasms metabolism, Proto-Oncogene Proteins c-bcl-2 pharmacology, Signal Transduction, Tumor Microenvironment, Tumor Suppressor Protein p53 pharmacology, Antineoplastic Agents therapeutic use, Autophagy drug effects, Molecular Targeted Therapy, Neoplasms drug therapy, Neoplasms pathology
- Abstract
Autophagy is a process in which long-lived proteins, damaged cell organelles, and other cellular particles are sequestered and degraded. This process is important for maintaining the cellular microenvironment when the cell is under stress. Many studies have shown that autophagy plays a complex role in human diseases, especially in cancer, where it is known to have paradoxical effects. Namely, autophagy provides the energy for metabolism and tumor growth and leads to cell death that promotes tumor suppression. The link between autophagy and cancer is also evident in that some of the genes that regulate carcinogenesis, oncogenes and tumor suppressor genes, participate in or impact the autophagy process. Therefore, modulating autophagy will be a valuable topic for cancer therapy. Many studies have shown that autophagy can inhibit the tumor growth when autophagy modulators are combined with radiotherapy and/or chemotherapy. These findings suggest that autophagy may be a potent target for cancer therapy.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.